Sherwin-Williams
SHW
$319.36
-0.52%
The Sherwin-Williams Company is the largest global manufacturer of paints and coatings, developing, producing, and distributing architectural paint, industrial coatings, and related products through three segments: the Paint Stores Group (its network of over 4,800 company-owned stores serving professional painters and contractors), the Consumer Brands Group (branded architectural paints sold through big-box retailers such as Lowe's), and the Performance Coatings Group (specialized industrial coatings for automotive refinishing, packaging, and industrial wood). Its vertically integrated, company-owned store model gives it a distinct competitive identity as a distribution-led platform rather than a pure manufacturer, with pricing power and customer intimacy that most commodity chemical peers cannot replicate. The current investor narrative centers on whether the company can sustain its multi-year margin expansion and pricing momentum against a soft new-residential and do-it-yourself demand backdrop, with the most recent quarterly results showing revenue growth of 7.5% year over year and a strong sequential rebound in net income. At the same time, the stock has materially lagged the broader market over the past year, and management's capital allocation — aggressive buybacks, a 47th consecutive annual dividend increase, and bolt-on acquisitions — is being weighed against a leveraged balance sheet and a premium valuation that leaves little room for execution missteps.…
SHW
Sherwin-Williams
$319.36
Related headlines
Investment Opinion: Should I buy SHW Today?
We rate Sherwin-Williams a Hold. The company's strong brand, dominant market position, and consistent cash flow generation are offset by a premium valuation (31.2x trailing P/E, 17.4x P/B) and significant relative underperformance (-20.2% vs. S&P 500 over one year). The analyst consensus target of $385.87 implies 20.8% upside, but we believe the risk/reward is balanced given the soft demand environment and leveraged balance sheet.
Supporting evidence for the Hold rating includes: 1) Revenue growth of 7.5% YoY in Q2 2026, which is solid but not spectacular; 2) Gross margin of 49.2% and operating margin of 16.1%, demonstrating pricing power; 3) Free cash flow of $3.21 billion TTM, providing flexibility for dividends and buybacks; and 4) A forward P/E of 23.6x, which is above the broader market average and leaves little room for error. The dividend yield of 0.99% is modest, and the payout ratio of 30.7% is conservative, but the stock is not cheap on any metric.
The biggest risks that could invalidate our thesis are: 1) A housing market downturn that pressures volumes and pricing; 2) Continued margin compression from raw material costs; and 3) A valuation de-rating if growth slows. We would upgrade to Buy if the stock pulls back to a more reasonable valuation (e.g., forward P/E below 20x) or if revenue growth accelerates above 10% with margin expansion. We would downgrade to Sell if revenue growth turns negative or if margins contract significantly. Relative to its history and peers, SHW appears overvalued, trading at a premium that assumes continued execution and a favorable demand environment.
Sign up to view all
SHW 12-Month Price Forecast
Sherwin-Williams is a high-quality company with a strong moat, consistent cash flows, and a shareholder-friendly capital allocation strategy. However, the stock's premium valuation (31.2x trailing P/E, 17.4x P/B) and significant relative underperformance (-20.2% vs. S&P 500 over one year) suggest that much of the good news is already priced in. The base case (55% probability) assumes mid-single-digit revenue growth and stable margins, leading to a target range of $340-$386. The bull case (25%) relies on a housing recovery and margin expansion, while the bear case (20%) reflects a housing downturn and margin compression. We would upgrade to bullish if revenue growth accelerates above 10% with margin expansion, or if the stock pulls back to a more attractive valuation (forward P/E below 20x). We would downgrade to bearish if revenue growth turns negative or if margins contract significantly.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Sherwin-Williams's 12-month outlook, with a consensus price target around $384.65 and implied upside of +20.4% versus the current price.
Average Target
$384.65
0 analysts
Implied Upside
+20.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$340 - $420
Analyst target range
Bulls vs Bears: SHW Investment Factors
The bull case rests on Sherwin-Williams' dominant market position, consistent revenue growth, strong margins, robust free cash flow, and a sell-side consensus that sees over 20% upside. The bear case highlights a premium valuation, significant relative underperformance, a leveraged balance sheet, and exposure to cyclical end markets. Currently, the bear evidence appears stronger on a near-term basis: the stock has underperformed the S&P 500 by over 20 percentage points in the past year, and its premium multiples (31x trailing P/E, 17x P/B) leave little room for error given mid-single-digit growth. The single most important tension is whether the company can sustain its margin expansion and pricing momentum against a soft demand backdrop; if revenue growth decelerates or margins compress, the premium valuation could compress sharply, but if growth accelerates and margins hold, the stock could re-rate toward analyst targets.
Bullish
- Analyst consensus sees 20.8% upside: The average analyst target price is $385.87, implying 20.8% upside from the current price of $319.36. With 23 analysts covering the stock and a consensus recommendation of 'buy' (mean rating 2.04), the sell-side remains constructive despite the stock's recent underperformance.
- Revenue growth accelerating to 7.5% YoY: Q2 2026 revenue grew 7.52% year over year to $6.79 billion, up from $6.31 billion in Q2 2025. This represents a meaningful acceleration from the roughly 3.5% growth implied in prior quarters, suggesting demand trends are stabilizing or improving.
- Strong profitability with 49.2% gross margin: Gross margin expanded to 49.17% in Q2 2026 from 49.38% in Q2 2025, remaining near multi-year highs. Operating margin of 18.13% and net margin of 12.43% demonstrate the company's pricing power and cost discipline even in a soft demand environment.
- Robust free cash flow of $3.21 billion TTM: Trailing twelve-month free cash flow stands at $3.21 billion, providing ample capacity to fund dividends, buybacks, and bolt-on acquisitions. The dividend payout ratio is a conservative 30.7%, supporting the 47th consecutive annual dividend increase.
Bearish
- Premium valuation leaves no margin for error: The stock trades at a trailing P/E of 31.2x, a forward P/E of 23.6x, and a price-to-book ratio of 17.4x. These multiples are rich for a company growing revenue at 7.5%, especially when compared to the broader market and chemical sector averages.
- Significant underperformance versus S&P 500: SHW has lagged the S&P 500 by 20.2 percentage points over the past year (relative strength -20.16%) and by 16.8 percentage points year-to-date. The stock is down 4.16% over one year while the S&P 500 gained 16.0%, indicating persistent relative weakness.
- Leveraged balance sheet with D/E of 2.81: The debt-to-equity ratio of 2.81 is elevated, and the current ratio of 0.87 indicates potential liquidity tightness. Interest expense of $135.9 million in Q2 2026 consumes a meaningful portion of operating income, and rising rates could pressure refinancing costs.
- Soft end markets and DIY weakness: The company faces a soft new-residential and do-it-yourself demand backdrop, which has pressured volumes. While revenue grew 7.5% YoY, much of that likely came from pricing rather than volume, and a prolonged housing downturn could stall growth.
SHW Technical Analysis
Beta
1.08
1.08x market volatility
Max Drawdown
-21.9%
Largest decline past year
52-Week Range
$290-$378
Price range past year
Annual Return
-4.2%
Cumulative gain past year
| Period | SHW Return | S&P 500 |
|---|---|---|
| 1m | -0.4% | +1.9% |
| 3m | -4.4% | +3.9% |
| 6m | -5.0% | +12.1% |
| 1y | -4.2% | +19.2% |
| ytd | -2.6% | +14.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SHW Fundamental Analysis
Quarterly Revenue
$6.8B
2026-06
Revenue YoY Growth
+7.5%
YoY Comparison
Gross Margin
49.2%
Latest Quarter
Free Cash Flow
$3.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SHW Overvalued?
PE
31.2x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 19x~56x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
20.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are significant. The debt-to-equity ratio of 2.81 is elevated, and with a current ratio of 0.87, the company has limited short-term liquidity cushion. Interest expense of $135.9 million in Q2 2026 represents a meaningful fixed cost, and any rise in borrowing costs could pressure net income. Additionally, the trailing EPS of $0.032 is alarmingly low relative to net income of $843.6 million, suggesting potential one-time charges or accounting distortions that could indicate earnings quality issues. The company's reliance on continued revenue growth to justify its premium valuation (31.2x trailing P/E) means any slowdown could trigger a sharp de-rating.
Market and competitive risks are also material. The stock's beta of 1.083 indicates it moves roughly in line with the broader market, but its relative strength has been poor: -20.2% over one year and -16.8% year-to-date versus the S&P 500. This underperformance could persist if investors continue to favor other sectors. The specialty chemicals industry is competitive, and while Sherwin-Williams' company-owned store model provides a moat, big-box retailers and online competitors could pressure pricing. Recent news highlights geopolitical tensions and Fed uncertainty driving market sell-offs, which could disproportionately impact premium-valued stocks like SHW. A rotation out of defensive names or a housing market downturn would exacerbate these pressures.
The worst-case scenario would involve a combination of a housing recession, margin compression from raw material inflation, and a valuation de-rating. If revenue growth stalls and margins contract, the stock could fall to its 52-week low of $289.86, representing a 9.2% decline from the current price of $319.36. In a more severe scenario, if the market applies a lower multiple (e.g., 20x forward earnings) to reduced earnings estimates, the stock could drop to the analyst low target of $340 (which is actually above current price, but that target may be stale) or lower. Given the max drawdown of -21.91% over the past year, a 20-25% decline from current levels is plausible in a bear case, implying a price near $240-$255. This would represent a loss of $64-$79 per share from current levels.
FAQ
The key risks include: 1) Financial risk: high debt-to-equity of 2.81 and low current ratio of 0.87 limit financial flexibility; 2) Market risk: the stock has underperformed the S&P 500 by 20.2% over one year, and a continued rotation out of premium-valued stocks could pressure the shares; 3) Operational risk: exposure to cyclical housing and DIY demand, with revenue growth dependent on pricing rather than volume; 4) Valuation risk: the premium multiple (31.2x trailing P/E) could compress if growth slows. Additionally, raw material inflation and competitive pressures could erode margins. The most severe risk is a housing downturn, which could drive the stock toward its 52-week low of $289.86, a 9.2% decline from current levels.
Our 12-month forecast for SHW has three scenarios: Bull case (25% probability) targets $385-$420, driven by a housing recovery and margin expansion; Base case (55% probability) targets $340-$386, assuming mid-single-digit revenue growth and stable margins; Bear case (20% probability) targets $240-$290, reflecting a housing downturn and margin compression. The base case is most likely, with the stock trading toward the analyst average target of $385.87. The key assumption is that revenue grows 5-7% and gross margin holds around 49%. However, given the stock's recent underperformance and premium valuation, we see limited upside in the near term and recommend a Hold.
SHW appears overvalued relative to its growth rate and the broader market. The trailing P/E of 31.2x and forward P/E of 23.6x are above the S&P 500 average, and the price-to-book ratio of 17.4x is exceptionally high. The PEG ratio is negative, reflecting low trailing EPS and negative growth expectations. Compared to its own history, the stock has rarely traded at such a premium, and the dividend yield of 0.99% is near historic lows. The market is pricing in continued margin expansion and mid-single-digit revenue growth, leaving little room for disappointment. A more reasonable valuation would be a forward P/E in the high teens, implying a stock price closer to $280-$300.
SHW is a high-quality company, but at the current price of $319.36, the risk/reward is balanced. The stock trades at a premium valuation (31.2x trailing P/E, 17.4x P/B) and has underperformed the S&P 500 by 20.2% over the past year. The analyst consensus target of $385.87 implies 20.8% upside, but that may be optimistic given soft housing and DIY demand. For long-term investors with a 5+ year horizon, SHW can be a core holding due to its strong brand, dividend growth, and cash flow. However, for short-term traders, the stock lacks a clear catalyst and could remain range-bound. We rate it a Hold, suggesting investors wait for a pullback or evidence of accelerating growth before buying.
SHW is best suited for long-term investment. The company has a 47-year track record of dividend increases, a strong competitive moat, and consistent free cash flow generation. However, the stock's beta of 1.083 and recent volatility (max drawdown of -21.91% over the past year) make it less ideal for short-term trading. The low dividend yield (0.99%) and premium valuation mean that near-term total returns may be modest. We recommend a minimum holding period of 3-5 years to allow for earnings growth and dividend compounding to drive returns. Short-term traders should look for entry points near the 52-week low of $289.86 or on a breakout above $350 with volume.